European shares subdued as luxury stocks, miners weigh

Reuters01-16
UPDATE 2-European shares subdued as luxury stocks, miners weigh

STOXX 600 logs fifth consecutive weekly gain despite Friday's dip

Novo Nordisk jumps 6.5% on positive Wegovy launch, UK approval

Luxury stocks fall, Richemont down 5.4% after BofA downgrade

Updates to after markets close

By Niket Nishant and Avinash P

Jan 16 (Reuters) - European shares were subdued on Friday, limited by weakness in luxury and mining stocks in a dour end to a week dominated by the start to a busy earnings season alongside geopolitical jitters.

The pan-European STOXX 600 .STOXX finished flat at 614.38 points, with the luxury index .STXLUXP falling 3.2% and logging its biggest daily fall since early October.

Richemont CFR.S was among the leading laggards, declining 5.4% after BofA global research cut its recommendation on the Swiss jewellery company to neutral from buy and told investors to wait, citing extended valuations after a recent rally.

"European equities aren't cheap anymore, but they're not expensive either. That said, the margin of safety that investors had previously is gone," said Michael Field, chief European equity strategist at Morningstar.

Still, the STOXX 600 logged its fifth-consecutive weekly gain, its longest winning streak since May 2025.

The index has scaled multiple record highs, led by strength in commodity-linked stocks as prices of safe-haven precious metals and crude oil soared earlier in the week on simmering geopolitical tensions over Iran and Venezuela.

On Friday, those tensions appeared to abate, sending mining stocks .SXPP down 1.9%.

"As you come to the end of the week (following) a pretty strong start to the year, maybe there's just a little bit of a pause as people reflect there are some good fundamental reasons for optimism, but there's a good amount of uncertainty in the world on the geopolitical side," said Richard Flax, chief investment officer at Moneyfarm.

Defence stocks .SXPARO added 1%, keeping a lid on losses on the STOXX index.

Danish drugmaker Novo Nordisk NOVOb.CO jumped 6.5% after analysts said its weight-loss pill Wegovy made an "encouraging" start after its launch this month. The healthcare index .SXDP also added 0.6%.

Britain's health regulator approved a higher dose of Wegovy for obesity patients, while Berenberg also raised its price target on the stock.

The week had witnessed a mixed bag of earnings updates from the likes of Richemont, BP BP.L and BE Semiconductor BESI.AS. Fourth quarter earnings were expected to decrease 4.1% from a year ago, with consumer cyclicals the hardest hit, according to data compiled by LSEG.

HSBC HSBA.L shares dipped 0.4%. The lender said it was undertaking a strategic review of its insurance business in Singapore, as part of efforts to simplify global operations.

Kongsberg Gruppen KOG.OL shares jumped 9.5%, the best individual performer on Friday, after at least two brokerages lifted price targets on the Norwegian defence equipment maker.

(Reporting by Niket Nishant, Avinash P and Johann M Cherian in Bengaluru; Editing by Mrigank Dhaniwala, Devika Syamnath and Alex Richardson)

((Niket.Nishant@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment